Caughey Elaine has filed 4 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 10557 shares of Kymera Therapeutics, Inc. ($KYMR) on March 01, 2023.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2023 | Kymera Therapeutics, Inc. | $KYMR | Caughey Elaine | Chief Business Officer | A | Common Stock | 10557 | $0.00 | 19,700.0000 | 53,933,229 | 115.47% | 0.02% |
| March 2, 2023 | Kymera Therapeutics, Inc. | $KYMR | Caughey Elaine | Chief Business Officer | S | Common Stock | 550 | $30.88 | 19,150.0000 | 53,933,229 | 2.79% | 0.00% |
| March 2, 2023 | Kymera Therapeutics, Inc. | $KYMR | Caughey Elaine | Chief Business Officer | S | Common Stock | 164 | $31.40 | 18,986.0000 | 53,933,229 | 0.86% | 0.00% |
| March 1, 2023 | Kymera Therapeutics, Inc. | $KYMR | Caughey Elaine | Chief Business Officer | A | Stock Option (Right to Buy) | 63338 | $0.00 | 63,338.0000 | 53,933,229 | 9999.99% | 0.12% |